ROSUTOR

This brand name is authorized in Nigeria.

Active ingredients

The drug ROSUTOR contains one active pharmaceutical ingredient (API):

1	Rosuvastatin UNII 83MVU38M7Q - ROSUVASTATIN CALCIUM
	Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles.
	Read more about Rosuvastatin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0600	Tablet	ROSUTOR 10 TABETS TAB 10 mg 3x10	71 RNW-PP-338890 ROSUTOR 10 TABETS ROSUVASTATIN CALCIUM 10MG Rosuvastatin Calcium 10mg Excipients Tablet core (same for all strengths) Cellulose Micryostalline (E460) Silica, colloidal anhydrous (E551) Magnesium stearate (E572) Povidone K30 (E1201) Croscarmellose Sodium (E468) Sodium laurilsulfate (E487) Lactose Monohydrate Hypromellose 2910 (E464) B4-0600 CARDIOVASCULAR SYSTEM Imported Products 310 POM 1 7/6/2023 REALS PHARMACEUTICALS LIMITED, PLOT 1, REALS PLAZA, JUNAID DOSUMNU STREET, CBD, ALAUSA IKEJA IKEJA LAGOS 8175048484 realspharm@realsreg.com SWISS PHARMA PVT LTD., 3709, G.I.D.C., PHASE-IV, VATVA, AHMEDABAD-382445, GUJARAT, INDIA, India	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA07	Rosuvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0600